Skip to main content
Equibles

FRED ALGER MANAGEMENT, LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 3520 NEW YORK, NY
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$627,985
-$13,325,420 QoQ
Shares Held
32,254
-89.1% QoQ
Ownership
0.038%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 172 holders
Holding Since
Mar 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FRED ALGER MANAGEMENT, LLC holds $805,760,903 across 54 Biotechnology names. MLTX ranks #43 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARWR
Arrowhead Pharmaceuticals, Inc.
 3,301,919 $269,139,417
2 DNTH
Dianthus Therapeutics, Inc. /DE/
 1,302,493 $126,967,017
3 TWST
Twist Bioscience Corp
 558,157 $57,423,192
4 RVMD
Revolution Medicines, Inc.
 259,468 $48,593,167
5 ASND
Ascendis Pharma A/S
 171,447 $45,728,343
6 COGT
Cogent Biosciences, Inc.
 1,072,830 $41,518,521
7 ROIV
Roivant Sciences Ltd.
 1,081,421 $38,271,489
8
1,439,697 $30,593,561

All Filings in MLTX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $627,985 32,254
2025-06-30 $13,953,405 295,623
2025-03-31 $25,117,360 642,881
2024-12-31 $36,484,807 673,773
2024-09-30 $33,608,661 666,574
2024-06-30 $28,977,505 659,029
2024-03-31 $33,489,446 666,722
2023-12-31 $48,951,288 810,586
2023-09-30 $47,478,207 832,951
2023-06-30 $38,127,855 747,605
2023-03-31 $2,287,018 106,920